Tag Archives: Tuberculosis
Spinal tuberculosis update (Pacific Region)
A recent seminar on orthopaedic infections took place organised by the Pacific Islands Orthopaedic Association. Here is the presentation: Zoom tutorials – Spine TB Ferguson 2020 final_cb. References are within the presentation. Some take home messages: Epidemiology High burdens of latent … Continue reading
Tuberculosis – recent epidemiological data from PNG
These recent papers will be useful to review/ discuss (especially the first two): PNG TB resistance survey PLOS 2016 Epidemiology of TB PNG 2008-2016 Aia et al WPSAR 2018 1471-2334-14-93 TB Gulf province PNG 12866_2014_Article_307 TB diversity Highlands
Recent update on TB diagnostic techniques – GenXpert MTB/RIF Ultra
Guest posting: Dr Ian Marr, Microbiology Registrar, Pathology NSW, Hunter The GenXpert used in most LMIC has cartridges for detection of Mycobacterium tuberculosis (MTB) – GenXpert MTB/RIF. These contain primers and molecular beacon probes for the detection of both MTB … Continue reading
Tuberculosis- drug resistant- online learning, mailing lists and references
Courtesy of Dr Suman Majumdar, Dr Catherine Berry and others. Therapeutics Recent presentation from our advanced trainee registrar concerning the new TB drugs: Brian_Chong 2017 New TB drugs. TB drug monographs : up-to-date clinical profiles of TB drugs including guidance on … Continue reading
Excellent new Lancet series of tuberculosis papers
See this recent Lancet edition. Article list below. Editorial comment Richard Horton et al (excerpt) : This latest Lancet Series is led by Salmaan Keshavjee, from Harvard Medical School’s Department of Global Health and Social Medicine. He helped bring together … Continue reading
Antimicrobial resistance: WHY it matters, HOW did it arise and WHAT can we do about it – PNG focus
Global status of AMR with focus on PNG Medical Symposium Sept 2015 Why does AMR matter? Antimicrobial resistance kills- mortality higher for resistant pathogens AMR hampers the control of infectious diseases – prolonged infectivity – eg. MDR-TB AMR increases the … Continue reading
Tuberculosis infection control – an essential priority
Control of healthcare TB transmission is an essential element of practice – protecting staff and other patients is paramount. Patients receiving drug therapy for drug susceptible TB are at increased risk for acquisition of MDR or XDR TB. WHO policy on … Continue reading